Navigation Links
Ventana Introduces the BenchMark Special Stains Platform
Date:3/19/2012

TUCSON, Ariz., March 19, 2012 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, is now introducing a novel platform for special stains, built on its industry-leading VENTANA BenchMark technology.  Answering customers' challenges with their current process, the new BenchMark Special Stains platform offers walk-away automation, baking through staining including deparaffinization, random batch access, connectivity to the VANTAGE workflow solution, and the revolutionary VENTANA CareGiver(1) remote support, creating an ideal system for laboratories worldwide.

Derek Wheeler, Histology Supervisor, The Reading Hospital and Medical Center, teamed up with Ventana to ensure the full customer experience was incorporated into the new system architecture.  "The improvement to workflow with the new BenchMark Special Stains due to independent slide heating and online deparaffinization is significant.  I've seen the value special stains automation brings my laboratory by freeing up my technicians for over 10 years now. The BenchMark Special Stains platform adds a much improved level of efficiency and excellent results."    

Ventana is the industry leader(2) in the special stains instrument market, and this next level of instrument automation will dramatically enhance testing efficiency over manual processes.  WATCH this revealing demonstration of manual staining workflow vs. the new BenchMark Special Stains instrument. 

After evaluating the instrument and slides Brian Le, MD Pathologist, The Reading Hospital and Medical Center said,   "Our team is impressed with the quality and consistency of the BenchMark Special Stains slides.  The technologists and histologists are enthusiastic about how the automation enhancements have improved the workflow during the day."

In addition to offering automation, quality, and consistency, the BenchMark Special Stains platform utilizes the same dynamic software interface as the BenchMark ULTRA platform, enabling enhanced ease of use and protocol editing.  As part of maintaining VENTANA world class safety standards, the platform and reagent kits are designed to minimize exposure for lab personnel.  When you combine these features with its connectivity to other VENTANA laboratory systems and VENTANA CareGiver remote support, the BenchMark Special Stains platform is currently the most comprehensive special staining solution on the market(3).

"Ventana is all about innovation in anatomic pathology," said Mara G. Aspinall, President, Ventana Medical Systems, Inc.  "Special Stains is a critical part of the lab workflow, and the BenchMark Special Stains platform embodies our commitment to empowering our customers with the most advanced diagnostic solutions so they can deliver the highest possible standard of patient care."

(1)VENTANA CareGiver remote support delivers a comprehensive histology remote connectivity solution for VENTANA systems including the BenchMark Special Stains platform, SYMPHONY H&E stainer and BenchMark ULTRA IHC/ISH stainer.

 

(2,3)Ventana internal sales and market assessments, 2011

About Ventana Medical Systems, Inc.                              
Ventana Medical Systems, Inc. ("VMSI") (SIX: RO, ROG; OTCQX: RHHBY), a member of the Roche Group, innovates and manufactures instruments and reagents that automate tissue processing and slide staining for cancer diagnostics. VENTANA solutions are used in clinical histology and drug development research laboratories worldwide. The company's intuitive, integrated staining, workflow management platforms, and digital pathology solutions optimize laboratory efficiencies to reduce errors, support diagnosis and inform treatment decisions for anatomic pathology professionals. Together with Roche, VMSI is driving personalized healthcare through accelerated drug discovery and the development of "companion diagnostics" to identify the patients most likely to respond favorably to specific therapies. Visit www.ventana.com to learn more.

VENTANA, the VENTANA logo, SYMPHONY, and BenchMark are trademarks of Roche.

VMSI Media Relations
Jacqueline Bucher
Director, Corporate Communications
Phone: 520-877-7288
e-mail: jacquie.bucher@ventana.roche.com

 


'/>"/>
SOURCE Ventana Medical Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Ventana Receives FDA Clearance for Ki-67 (30-9) Image Analysis and Digital Read Applications
2. Ventana Medical Systems, Inc. to Collaborate with Bayer on Companion Diagnostic Test for New Biological Cancer Therapy
3. Syndax Pharmaceuticals Signs Agreement with Ventana Medical Systems, Inc. to Develop Companion Diagnostic Test for Entinostat
4. Ventana Medical Systems, Inc. and Advanced Cell Diagnostics Enter Worldwide Co-Promotion Agreement for Fully Automated RNA In Situ Hybridization Assay Systems
5. Ventana Medical Systems, Inc. Introduces Groundbreaking Laboratory Workflow Integration
6. Ventana Medical Systems, Inc. Unveils High-throughput Slide Scanner for Digital Pathology
7. Ventana Medical Systems, Inc. Receives FDA Approval for the First Fully Automated Diagnostic Assay for HER2 Gene Status Determination in Breast Cancer Patients
8. Ventana Medical Systems, Inc. Launches Virtuoso Software for Digital Pathology
9. CareGiver, Ventana Medical Systems, Inc. Remote Instrument Support, Has Expanded to Include the Ventana BenchMark ULTRA Automated Stainer
10. Endologix Announces First Clinical Implant of Ventana™ Stent Graft
11. Cynosure Introduces Enhanced Elite+ and Apogee+ Workstations for Faster Aesthetic Treatments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... of Australia,s successful biotechnology scientists, Dr ... company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). Noxopharm is ... the ASX. Noxopharm is a clinic-ready company with its ... clinical study later this year. ... facing cancer patients - the ability of cancers to become resistant ...
(Date:6/26/2016)... 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ... Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) expired ... Time). As previously announced on May 31, ... merger agreement under which Jazz Pharmaceuticals has commenced a ...
(Date:6/26/2016)... Ontario , June 27, 2016  VMS Rehab ... Company,s Board will take whatever measures required to build ... Company,s stock which is currently listed on the OTC ... Wexler, Company Chairman and CEO, "We are seeing an ... difficult to understand, not only by the Company, but ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... 27, 2016 , ... The OSHA Training Center at ... Center headquartered in Northern California, has issued an important reminder to employers to ... Employers with workers exposed to high temperatures should establish a complete heat ...
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal ... Final Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. ... Cut Pro X users can now reveal the media of their split screens ...
(Date:6/27/2016)... ... June 27, 2016 , ... TherapySites, ... today its affiliation with Tennessee Counseling Association. This new relationship allows ... the Tennessee Counseling Association, adding exclusive benefits and promotional offers. , "TCA is ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... today announced its strategic partnership with Connance, a healthcare industry leader providing ... companies’ proven, proprietary technology combine to provide health systems, hospitals and ambulatory ...
(Date:6/27/2016)... ... June 27, 2016 , ... A revolution is underway. ... ambulance transport experience for the millions of people who require these medical transport ... taxi industry through the use of technology. Now, SmartEMS has put forth an ...
Breaking Medicine News(10 mins):